Exiqon Logs 11 Percent Revenue Growth in Q2 Buoyed by miRNA PCR Products
August 11, 2011
Exiqon Logs 11 Percent Revenue Growth in Q2 Buoyed by miRNA PCR Products
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Takara Bio to Distribute Exiqon Products in Asia
October 17, 2012 / GenomeWeb Daily News - EMBL Group Devises New qPCR-based MicroRNA-Profiling Method; Seeks Collaborators
September 15, 2011 / PCR Insider - Exiqon Establishes Center of Excellence at U of Miami School of Medicine
August 23, 2011 / PCR Insider - Exiqon Presents Data Supporting Use of PCR-Based miRNA Assay as Blood-Based Colon Cancer Dx
September 30, 2010 / PCR Insider - Exiqon Presents Data from Colon Cancer Biomarker Study
June 7, 2012 / Gene Silencing News